MKS Instruments (Nasdaq:MKSI), rated OVERWEIGHT by Barclays Capital
MKS Instruments is a provider of niche parts and process controllers to manufacturers of capital equipment within the semiconductor industry (62% of sales). Here it's the market leader, having roughly a 34% share of its addressable market. It booked a 2010 turnover of $853m, with just over half being derived from outside America, underpinned by its cutting-edge science, which is protected by 650 patents.
Yet in July the stock slumped because of a temporary deceleration in orders. As a result the board trimmed its guidance for Q3 EPS to between 40 and 60 cents on turnover of $180m-$210m. Chief executive officer Leo Berlinghieri added that there was some softening in the chip sector after a few quarters of strong shipments in smartphones, tablets and other mobile devices.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
But a small air-pocket in demand should not be a surprise in this cyclical industry. What's more, the firm is diversifying its product reach and incorporating its clever instrumentation into other exciting areas, such as flat-panel displays, solar cells and data storage. Better still, regardless of any recession, MKS has a cast-iron balance sheet that should enable it to ride out most storms comfortably. Indeed, with cash of $496m (or $9.30per share) and net tangible assets of $15 per share, it could even take advantage of present low valuations to snap up rivals.
Wall Street is forecasting a second-half turnover and adjusted EPS of $379m and $0.95 respectively. That puts the shares on a "six-month run-rate" p/e ratio of 12.2, dropping to a mouthwatering eight, if the cash pile is stripped out. Instead, I would value the group on an eight times enterprise value to EBITA multiple. Adjusting for the net funds, that produces an intrinsic worth of over $31 per share.
Any prolonged downturn would inevitably affect margins through lower capacity utilisation and pricing. For British investors there's foreign exchange risk to consider too. Nonetheless, MKS Instruments has top-notch products and should be a long-term beneficiary of the growth in electronics. Barclays Capital has a price target of $32 per share.
Rating: BUY at $23.1
-
Paying the grandkids’ school fees could generate a shock IHT billPrivate school fees have soared as a result of the government’s VAT policy, meaning more grandparents are helping out – but what are the tax implications?
-
Number of savings deals hits record high – as interest rates slump to two-year lowSavers have more choice than ever when it comes to choosing a savings account or cash ISA. But, the interest rates on offer continue to fall. What’s next for the savings market?
